Keywords: Novo Nordisk, Financial results, R&D update, Diabetes care

Novo Nordisk ups forecast on strong diabetes drug sales

Article | 09 August 2012

Print This

Denmark’s Novo Nordisk, the world’s largest insulin producer, this morning posted financial results for the second ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in